Press release
Global Enteric Disease Testing & Treatment Market is expected to reach USD 4.9 billion by 2025 | Analysis by Industry Share Types Region and Overview- Cepheid Coris Bioconcept, Diasorin, Meridian Bioscience, Inc, Quest Diagnostics and Trinity Biotech.
Global Enteric Disease Testing & Treatment Market
The Global Enteric Disease Testing & Treatment Market is expected to reach USD 4.9 billion by 2025, from USD 3.69 billion in 2017 growing at a CAGR of 3.6% during the forecast period of 2018 to 2025.
The upcoming market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.
For In depth Information Get Free Sample Copy of this Report@ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-enteric-disease-testing-treatment-market
Market Definition: Global Enteric Disease Testing & Treatment Market
According to the World Health Organizationm, in 2015, approximately 1940 cases were reported in Uganda. According to the CDNA (Communicable Diseases Network Australia), in 2015,approximately 116 cases of typhoid fever were notified in Australia.
According to the Center for Disease Control and Prevention, in 2013, approximately 5,700 cases occurred each year in U.S. According to the Tropical Health and International Medicine, in 2016, approximately 26.9 million cases occurred at worldwide.
Due the increasing cases related to enteric disease such as typhoid fever the demand of enteric disease testing and treatment market is rising.
Request for Detailed TOC: https://databridgemarketresearch.com/toc/?dbmr=global-enteric-disease-testing-treatment-market
Top Key Players:
• Alere, Inc.
• Becton Dickinson & Company
• Biomerica, Inc.
• Biomerieux
• Bio-Rad
• Cepheid Coris Bioconcept
• Diasorin
• Meridian Bioscience, Inc
• Quest Diagnostics and Trinity Biotech.
• Meridian Bioscience Inc.
• Thermo Fisher Scientific
• Mobidiag
• Siemens
• R-Biopharm
• BioConnections
• Eiken Chemical
• BD
• Mobidiag
• GlaxoSmithKline
• Bharat Biotech
• Bayer
• Sanofi S. A.
• Pfizer
• Among others..
Inquire Before Buying @ https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-enteric-disease-testing-treatment-market
Customize report of "Global Enteric Disease Testing & Treatment Market" as per customers requirement also available.
Market Segmentations:
Global Enteric Disease Testing & Treatment Market is segmented on the basis of
• Therapeutics
• Testing Technology
• Geography
Market Segmentations in Details:
By Therapeutics
• Campylobacter
• Cryptosporidium
• E-coli
• Enteroviruses
• Rhino Viruses
• RotaVirus (REOVIRUS)
• Salmonellosis
• Shigellosis
By Testing Technology
• Molecular Diagnostics
• Monoclonal Antibodies
• Immunoassays
• Differential Light Scattering
• Information Technology
• Artificial Intelligence
• Liposomes
• Flow Cytometry
• Chromatography
• Diagnostic Imaging
• Gel Microdroplets
• Others
By Geography
North America
• U. S.
• Canada,
• Mexico
Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Turkey
• Belgium
• Netherlands
• Switzerland
• Rest of Europe
Asia-Pacific
• Japan
• China
• South Korea
• India
• Australia
• Singapore
• Thailand
• Malaysia
• Indonesia
• Philippines
• Rest of Asia Pacific
South America
• Brazil
• Rest of South America
Middle East & Africa
• South Africa
• Saudi Arabia
• UAE
• Rest of MEA
Competitive Analysis: Global Enteric Disease Testing & Treatment Market
The global enteric disease testing and treatment market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of global continuous glucose monitoring market for global, Europe, North America, Asia Pacific and South America.
For instance, in 2017, Meridian Bioscience, Inc(U.S.) expanded its ImmunoCard STAT product line by addition of Immuno Card STAT FLU A&B which detects the presence of influenza A & B in nasal and nasopharyngeal swabs.
Speak to Author of the report @ https://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-enteric-disease-testing-treatment-market
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to complex business challenges and initiates an effortless decision-making process.
Contact Us-
Data Bridge Market Research
US: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Enteric Disease Testing & Treatment Market is expected to reach USD 4.9 billion by 2025 | Analysis by Industry Share Types Region and Overview- Cepheid Coris Bioconcept, Diasorin, Meridian Bioscience, Inc, Quest Diagnostics and Trinity Biotech. here
News-ID: 1748066 • Views: …
More Releases from Data Bridge Market Research
Women's Footwear Market to Grow at a CAGR of 4.70% by 2031 | Industry Trends, Si …
The global women's footwear market size was valued at USD 30.5 billion in 2023 and is projected to reach USD 44.04 billion by 2031, with a CAGR of 4.70% during the forecast period of 2024 to 2031.
Women's footwear refers to shoes specifically designed and manufactured for women. This category encompasses a wide range of styles, including heels, flats, sneakers, boots, sandals, and more, tailored to meet the diverse needs…
Financial Crime and Fraud Management Solutions Market to Grow at a CAGR of 4.7% …
Data Bridge Market Research analyses that the financial crime and fraud management solutions market will exhibit a CAGR of 4.7% for the forecast period of 2022-2029.
Financial crime risk management is more important than ever. Financial institutions work hard to ensure compliance while keeping costs under control. Meanwhile, criminals are developing new systems that necessitate new regulations and risk management solutions that are adaptive.
Browse More About This Research Report @…
Traumatic Brain Injuries Treatment Market to Grow at a CAGR of 6.20% by 2030 | I …
Data Bridge Market Research analyses that the global traumatic brain injuries treatment market which was USD 3.46 billion in 2022, and would rocket up to USD 5.53 billion by 2030, and is expected to undergo a CAGR of 6.20% during the forecast period.
Traumatic brain injuries treatments are among the various therapeutic methods available in the healthcare industry developed for the treatment of traumatic brain injuries of different degrees. Majorly, the…
Tipper Pads Market to Exhibit a Remarkable CAGR of 2.60% by 2029, Size, Share, T …
Data Bridge Market Research analyses that the tipper pads market was valued at USD 4.75 billion in 2021 and is expected to reach the value of USD 5.83 billion by 2029, at a CAGR of 2.60% during the forecast period of 2022-2029.
Market Definition:
Tipper pads are found on tippers and dump trucks. Tipper pads are used to protect tipper truck chassis. Tipper trucks are widely used in the construction industry for…
More Releases for Disease
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the…
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol…
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene…
Gaucher Disease Treatment Market, by Disease Type, Therapy Type
Gaucher disease is an autosomal recessive inherited metabolism disorder where a type of fat (lipid) called glucocerebroside is unable to degrade. Body synthesis enzyme called glucocerebrosidase, which breakdowns and reprocesses glucocerebroside. Gaucher disease is caused by mutations of a single gene called GBA, which leads to very low levels of glucocerebrosidase enzyme leading to low degradation of glucocerebroside. There are three types of Gaucher disease namely: type 1, type 2,…
Autoimmune Disease Diagnostic Market By Disease, Tests Type, Regions, Companies
"The Latest Research Report Autoimmune Disease Diagnostic Market, Global Forecast, By Disease, Tests Type, Regions, Companies provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"
Autoimmune Disease Diagnostic Market is anticipated to exceed US$ 18 Billion, experiencing a significant growth over the forecast period. Autoimmune diseases take place when there is disruption of the usual control process (immune system of the body becomes…
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and…
